Organization Overview
Alternative names
allogeneic mesenchymal stem cells (1 trial)
allogenic mesenchymal stem cell derived from olfactory mucosa (4 trials)
autologous adipose-derived mesenchymal stem cells (4 trials)
autologous dendritic cells primed with muc-1/wt-1 peptides (1 trial)
Burns (Phase 2)
Chronic Periodontitis (Phase 2)
Corneal Diseases (Phase 2)
Corneal Ulcer (Phase 2)
Endometritis (Phase 2)
Enuresis (Phase 2)
Gingival Recession (Phase 2)
Gynatresia (Phase 2)
Lung Diseases, Interstitial (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Periodontitis (Phase 2)
Pneumonia (Phase 2)
Pneumonia, Viral (Phase 2)
Ulcer (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Urinary Incontinence (Phase 2)
Urinary Incontinence, Stress (Phase 2)
Wounds and Injuries (Phase 2)